medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2020, Número 1

<< Anterior Siguiente >>

Medicina & Laboratorio 2020; 24 (1)


La próstata desde una perspectiva inmunológica

Puerta-Suárez J, Cardona-Maya WD

Idioma: Español
Referencias bibliográficas: 53
Paginas: 13-35
Archivo PDF: 1001.18 Kb.


RESUMEN

Los procesos inflamatorios e infecciosos que se desencadenan en la próstata, primordial glándula reproductiva masculina, originan las tres principales enfermedades de este órgano: prostatitis, hiperplasia prostática benigna y cáncer. Para entender la relación que existe entre estas tres patologías y los procesos de infección e inflamación, se realizó una revisión de la literatura científica, a conveniencia, en la base de datos PubMed, empleando los términos próstata, prostatitis, hiperplasia prostática benigna y cáncer de próstata. La literatura revisada resalta la importancia del adecuado funcionamiento del sistema inmune en el tejido prostático para eliminar los microorganismos causantes de infecciones, proceso a través del cual se desencadena la inflamación del tejido. Además, infecciones urinarias ascendentes, que culminan en prostatitis crónica, favorecen el desarrollo de la hiperplasia prostática benigna, agrandamiento y fibrosis de la próstata en hombres adultos, e incluso su progresión a cáncer en individuos genéticamente susceptibles. Por otro lado, las limitaciones en el diagnóstico de las alteraciones prostáticas promueven la inflamación crónica, y el uso indiscriminado de antibióticos de amplio espectro para el tratamiento de la prostatitis, impulsa la diseminación sexual de microorganismos multirresistentes al tratamiento. Las alteraciones prostáticas, en especial la prostatitis, continúan siendo patologías enigmáticas de difícil diagnóstico y tratamiento. El estudio de la próstata, sus alteraciones y su relación con el sistema inmune contribuirán a limitar el uso indiscriminado de antibióticos y a reducir los costos en salud y los efectos sobre la calidad de vida de los individuos afectados.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Verze P, Cai T, Lorenzetti S. The role of the prostate in male fertility, health and disease. Nat Rev Urol 2016;13:379-386.

  2. Zhang R, Sutcliffe S, Giovannucci E, Willett WC, Platz EA, Rosner BA, et al. Lifestyle and risk of chronic prostatitis/chronic pelvic pain syndrome in a cohort of United States Male Health Professionals. J Urol 2015;194:1295- 1300.

  3. Videcnik Zorman J, Maticic M, Jeverica S, Smrkolj T. Diagnosis and treatment of bacterial prostatitis. Acta Dermatovenerol Alp Pannonica Adriat 2015;24:25-29.

  4. Wagenlehner FM, Diemer T, Naber KG, Weidner W. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status. Andrologia 2008;40:100-104.

  5. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6- 11; discussion S11-12.

  6. Platz EA, De Marzo AM. Epidemiology of inflammation and prostate cancer. J Urol 2004;171:S36-40.

  7. Aaron L, Franco OE, Hayward SW. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol Clin North Am 2016;43:279-288.

  8. Aaron L, Franco O, Hayward SW. Review of prostate anatomy and embryology and the etiology of BPH. Urol Clin North Am 2016;43:279.

  9. Goel T, Sankhwar SN. Comparative study of zinc levels in benign and malignant lesions of the prostate. Scand J Urol Nephrol 2006;40:108-112.

  10. Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JS-G, Gómez- Millán J, et al. The urinary tract microbiome in health and disease. Eur Urol Focus 2018:4:128- 138.

  11. Nickel JC, Stephens A, Landis JR, Chen J, Mullins C, van Bokhoven A, et al. Search for microorganisms in men with urologic chronic pelvic pain syndrome: A culture-independent analysis in the MAPP Research Network. J Urol 2015;194:127-135.

  12. Schuppe H-C, Pilatz A, Hossain H, Diemer T, Wagenlehner F, Weidner W. Urogenital infection as a risk factor for male infertility. Dtsch Ärztebl Int 2017;114:339.

  13. De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder F, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation. Eur Urol 2011;60:106-117.

  14. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 2013;112:432-441.

  15. Ficarra V, Rossanese M, Zazzara M, Giannarini G, Abbinante M, Bartoletti R, et al. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy. Curr Urol Rep 2014;15:463.

  16. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256.

  17. Tepaamorndech S, Oort P, Kirschke CP, Cai Y, Huang L. ZNT7 binds to CD40 and influences CD154-triggered p38 MAPK activity in B lymphocytes-a possible regulatory mechanism for zinc in immune function. FEBS Open Bio 2017;7:675-690.

  18. Robert G, Smit F, Hessels D, Jannink S, Karthaus HF, Aalders T, et al. Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia. Prostate 2011;71:1701- 1709.

  19. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP. Monocyte chemotactic protein‐1 (MCP‐1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate 2010;70:473-481.

  20. Nederlof I, Meuleman T, van der Hoorn M, Claas F, Eikmans M. The seed to success: The role of seminal plasma in pregnancy. J Reprod Immunol 2017;123:24-28.

  21. Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S, et al. Inflammation, microbiota, and prostate cancer. Eur Urol Focus 2016;2:374-382.

  22. Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, et al. Comprehensive overview of prostatitis. Biomed Pharmacother 2017;94:1064-1076.

  23. Kurkar A, Elderwy AA, Awad SM, Abulsorour S, Aboul-Ella HA, Altaher A. Hyperuricemia: A possible cause of hemospermia. Urology 2014;84:609-612.

  24. De Luca S, Passera R, Bollito E, Manfredi M, Scarpa RM, Sottile A, et al. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other nonneoplastic alterations of the prostate at initial biopsy. Anticancer Res 2014;34:7159-7165.

  25. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011;186:1830-1834.

  26. Rajarubendra N, Lawrentschuk N, Bolton DM, Klotz L, Davis ID. Prostate cancer immunology– an update for Urologists. BJU Int 2011;107:1046-1051.

  27. Kim SH, Jung KI, Koh JS, Min KO, Cho SY, Kim HW. Lower urinary tract symptoms in benign prostatic hyperplasia patients: Orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int 2013;90:144-149.

  28. Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund‐Johansen T, Naber KG, Hartung R, et al. The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 2007;100:733-737.

  29. Lucia MS, Lambert JR. Growth factors in benign prostatic hyperplasia: Basic science implications. Curr Urol Rep 2008;9:272-278.

  30. Sampson N, Untergasser G, Plas E, Berger P. The ageing male reproductive tract. J Pathol 2007;211:206-218.

  31. Motrich RD, Breser ML, Sanchez LR, Godoy GJ, Prinz I, Rivero VE. IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome. Pain 2016;157:585-597.

  32. Sanchez LR, Breser ML, Godoy GJ, Salazar FC, Mackern-Oberti JP, Cuffini C, et al. Chronic infection of the prostate by Chlamydia muridarum is accompanied by local inflammation and pelvic pain development. Prostate 2017;77:517-529.

  33. Gimenes F, Souza RP, Bento JC, Teixeira JJ, Maria-Engler SS, Bonini MG, et al. Male infertility: A public health issue caused by sexually transmitted pathogens. Nat Rev Urol 2014;11:672-687.

  34. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: The evidence. Histopathology 2012;60:199-215.

  35. Dohle GR. Inflammatory-associated obstructions of the male reproductive tract. Andrologia 2003;35:321-324.

  36. Restrepo B, Cardona Maya W. Anticuerpos antiespermatozoides y su asociación con la fertilidad. Actas Urol Esp 2013;37:571-8

  37. Han IH, Kim JH, Kim SS, Ahn MH, Ryu JS. Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis. Parasite Immunol 2016;38:678-687.

  38. Bissett L. The control of urinary tract infection in hospitalised older people. Nurs Times 2004;100:54-56.

  39. Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr 2016;4.

  40. Hochreiter WW, Duncan JL, Schaeffer AJ. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 2000;163:127-130.

  41. Ittmann M. Anatomy and histology of the human and murine prostate. Cold Spring Harb Perspect Med 2018;8:a030346.

  42. Guazzone VA, Jacobo P, Theas MS, Lustig L. Cytokines and chemokines in testicular inflammation: A brief review. Microsc Res Techniq 2009;72:620-628.

  43. Ouzounova‐Raykova V, Ouzounova I, Mitov I. May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection? Andrologia 2010;42:176-181.

  44. Kumar S, Dave A, Wolf B, Lerma EV. Urinary tract infections. Dis Mon 2015;61:45-59.

  45. Shang Y, Liu C, Cui D, Han G, Yi S. The effect of chronic bacterial prostatitis on semen quality in adult men: a meta-analysis of case-control studies. Sci Rep 2014;4:7233.

  46. Shoskes DA. Chronic prostatitis/chronic pelvic pain syndrome; Springer Science & Business Media. 2008.

  47. Wood N, Qureshi A, Mughal F. Positioning, telling, and performing a male illness: Chronic prostatitis/chronic pelvic pain syndrome. Br J Health Psychol 2017;22:904-919.

  48. Al-Maghrebi M, Kehinde EO, Al-Mulla F, Anim JT. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression. Ann Saudi Med 2012;32:262-268.

  49. Mackern-Oberti JP, Motrich RD, Breser ML, Sánchez LR, Cuffini C, Rivero VE. Chlamydia trachomatis infection of the male genital tract: An update. J Reprod Immunol 2013;100:37-53.

  50. Motrich R, Maccioni M, Riera C, Rivero V. Autoimmune prostatitis: State of the art. Scand J Immunol 2007;66:217-227.

  51. Puerta-Suárez J, Cardona-Maya W. Alergia al plasma seminal humano: ¿mito o realidad? Rev Chil Obstet Ginecol 2013;78:193-200.

  52. Puerta-Suarez J, Cardona-Maya W. Postorgasmic illness syndrome: Semen allergy in men. Actas Urol Esp 2013;37:593.

  53. Franco-Cuadros L, Puerta-Suarez J, Cadavid- Jaramillo A, Cardona-Maya W. Alergia al semen. Rev Cuba Obstet Ginecol 2013;39:383-388.




2020     |     www.medigraphic.com